Article Data

  • Views 2729
  • Dowloads 148

Case Reports

Open Access

Follicular variant of thyroid papillary carcinoma arising from ovarian mature cystic teratoma: a case report

  • Dae-Hyung Lee1,*,

1Department of Obstetrics & Gynecology, College of Medicine, Yeungnam University Medical Center, Daegu, 42415, Republic of Korea

DOI: 10.31083/j.ejgo.2020.06.2211 Vol.41,Issue 6,December 2020 pp.1056-1060

Submitted: 04 August 2020 Accepted: 28 August 2020

Published: 15 December 2020

*Corresponding Author(s): Dae-Hyung Lee E-mail: leebhy@ynu.ac.kr

PDF (4.47 MB) View Full-text

Abstract

Malignant transformation of mature cystic teratoma of the ovary occurs very rarely. As reported in previously published literature, the incidence of malignant transformation is less than 2%. Among them, squamous cell carcinoma is the most common neoplasm; however, a follicular variant of thyroid papillary carcinoma arising from mature cystic teratoma is extremely rare. Here, I have reported a case of a follicular variant of thyroid papillary carcinoma arising from a mature ovarian cystic teratoma. A 65-year-old woman presented to our hospital for an incidentally detected ovarian mass. The patient underwent laparoscopic salpingo-oophorectomy for a suspicion of benign ovarian mass. Postoperative pathologic examination revealed a follicular variant of papillary carcinoma arising in the thyroid tissue of a mature ovarian cystic teratoma. Therefore, this case highlights that there is a possibility of an unusual but malignant transformation in ovarian teratoma.


Keywords

Mature cystic teratoma; Papillary thyroid carcinoma; Ovarian neoplasm.


Cite and Share

Dae-hyung Lee. Follicular variant of thyroid papillary carcinoma arising from ovarian mature cystic teratoma: a case report. European Journal of Gynaecological Oncology. 2020; 41(6): 1056-1060. doi: 10.31083/j.ejgo.2020.06.2211

References

[1] Lai P., Hsieh S., Chien J.C., Fang C., Chan W.P., Yu C.: “Malignant transformation of an ovarian mature cystic teratoma: computed tomography findings”. Arch. Gynecol. Obstet., 2005, 271, 355-357.

[2] Yamaguchi K., Mandai M., Fukuhara K., Higuchi T., Hamanishi J., Takakura K., et al.: “Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period”. Oncol. Rep., 2008, 19, 705-711.

[3] Al-Rayyan E.S., Duqoum W.J., Sawalha M.S., Nascimento M.C., Pather S., Dalrymple C.J., et al.: “Secondary malignancies in ovarian dermoid cyst”. Saudi Med. J., 2009, 30, 524-528.

[4] Tangjitgamol S., Manusirivithaya S., Sheanakul C., Leelahakorn S., Thawaramara T., Jesadapatarakul S.: “Squamous cell carcinoma arising from dermoid cyst: case reports and review of literature”. Int. J. Gynecol. Cancer, 2003, 13, 558-563.

[5] Kelley R.R., Scully R.E.: “Cancer developing in dermoid cysts of the ovary - a report of 8 cases, including a carcinoid and a leiomyosarcoma”. Cancer, 1961, 14, 989-1000.

[6] Climie A.R.W., Heath L.P.: “Malignant degeneration of benign cys-tic teratomas of the ovary. Review of the literature and report of a chondrosarcoma and carcinoid tumor”. Cancer, 1968, 22, 824-832.

[7] Peterson W.F.: “Malignant degradation of benign cystic teratomas of the ovarya collective review of the literature”. Obstet. Gynecol. Surv., 1957, 12, 793-830.

[8] Kikkawa F., Nawa A., Tamakoshi K., Ishikawa H., Kuzuya K., Sug-anuma N., et al.: “Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary”. Cancer, 1998, 82, 2249-2255.

[9] Tseng C., Chou H., Huang K., Chang T., Liang C., Lai C., et al.: “Squamous cell carcinoma arising in mature cystic teratoma of the ovary”. Gynecol. Oncol., 1996, 63, 364-370.

[10] Chiang A.J., Chen M.Y., Weng C.S., Lin H., Lu C.H., Wang P.H., et al.: “Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: A Taiwanese gynecologic oncology group (TGOG) study”. J. Gynecol. Oncol., 2017, 28, e69.

[11] Dos Santos L., Mok E., Iasonos A., Park K., Soslow R.A., Aghajanian C., et al.: “Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature”. Gynecol. Oncol., 2007, 105, 321-324.

[12] Kashimura M., Shinohara M., Hirakawa T., Kamura T., Matsukuma K.: “Clinicopathologic study of squamous cell carcinoma of the ovary”. Gynecol. Oncol., 1989, 34, 75-79.

[13] Von Kahlden C.: “Ueber eine Eigenthumliche Form des Ovarialcar-cinoms”. Zentralbl allg Path., 1895, 7, 257.

[14] Rim S.M., Kim S.M., Choi H.S.: “Malignant transformation of ovarian mature cystic teratoma”. Int. J. Gynecol. Cancer, 2006, 16, 140- 144.

[15] Dane C., Ekmez M., Karaca A., Ak A., Dane B.: “Follicular variant of papillary thyroid carcinoma arising from a dermoid cyst: a rare malignancy in young women and review of the literature”. Taiwan. J. Obstet. Gynecol., 2012, 51, 421-425.

[16] Hong K., Han A.K.W., Kim M., Yun B.S., Jun H.S., Seong S.J., et al.: “Successful in vitro fertilization pregnancy and delivery after a fertility-sparing laparoscopic operation in a patient with a papillary thyroid carcinoma arising from a mature cystic teratoma”. Clin. Exp. Reprod. Med., 2019, 46, 140-145.

[17] Cokmez H., Gulbahar A., Yigit S., Aydin C.: “Oncocytic and tall columnar type papillary thyroid carcinoma arising on a mature cystic teratoma: a case report and literature review”. J. Pak. Med. Assoc., 2019, 69, 116-119.

[18] Iwahashi N., Deguchi Y., Horiuchi Y., Noguchi T., Yahata T., Ota N., et al.: “Live birth following laparoscopic fertility‑sparing surgery for papillary thyroid carcinoma arising from mature ovarian cystic teratoma: a case report”. Mol. Clin. Oncol., 2018, 9, 613-616.

[19] Kurman R., Telinde R.: “Blaustein’s pathology of the female genital tract”. 5th ed. New York: Springer Verlag, 2002.

[20] Park S.B., Kim J.K., Kim K.R., Cho K.S.: “Preoperative diagnosis of mature cystic teratoma with malignant transformation: analysis of imaging findings and clinical and laboratory data”. Arch. Gynecol. Obstet., 2007, 275, 25-31.

[21] DeSimone C.P., Lele S.M., Modesitt S.C.: “Malignant strumaovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy”. Gynecol. Oncol., 2003, 89, 543-548.

Submission Turnaround Time

Top